ROBERT SMITH: Open Payments
NPI 1083609135 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 82 payments from 19 companies in 2025. Trend: 2023 $2,673 · 2024 $2,955 · 2025 $3,062
Food & beverage: $3,062
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $450 |
| AstraZeneca Pharmaceuticals LP | 7 | $417 |
| Corcept Therapeutics | 7 | $412 |
| Novo Nordisk Inc | 12 | $250 |
| Exact Sciences Corporation | 4 | $209 |
| Amgen Inc. | 21 | $188 |
| Baxter Healthcare | 1 | $150 |
| Boston Scientific Corporation | 1 | $146 |
| Edwards Lifesciences Corporation | 1 | $136 |
| Lilly USA, LLC | 3 | $129 |
Products named: Kerendia, Korlym, Ozempic, AIRSUPRA, Cologuard Collection Kit, FLOSEAL, AMS 700, INSPIRIS RESILIA AORTIC VALVE.
Industry payments across TX — which companies pay providers there.
